Anacin
- Product NDC
- 63736-200
- Requested package NDC
- 63736-200-91
- 11-digit product format
- 637360200
- Labeler code
- 63736
- Product ID
- 63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Asprin and Caffeine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Insight Pharmaceuticals LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2009-06-25
- Substance
- ASPIRIN; CAFFEINE
- Active strength
- 400; 32 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63736-200 | 63736-200-91 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anacin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 400 mg/1 |
| CAFFEINE | 32 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63736-200-04 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-04 | Anacin | 4 in 1 BLISTER PACK | TABLET | 4 | 9 | |
| 63736-200-30 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-30 | Anacin | 30 in 1 BOTTLE | TABLET | 30 | 9 | |
| 63736-200-50 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-50 | Anacin | 50 in 1 BOTTLE | TABLET | 50 | 9 | |
| 63736-200-90 | Anacin | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 63736-200-90 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-91 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-91 | Anacin | 130 in 1 BOTTLE | TABLET | 130 | 9 | |
| 63736-200-92 | Anacin | 125 in 1 BOX | TABLET | 125 | 9 | |
| 63736-200-92 | Anacin | 1 in 1 POUCH | TABLET | 1 | 9 | |
| 63736-200-93 | Anacin | 300 in 1 BOTTLE | TABLET | 300 | 9 | |
| 63736-200-93 | Anacin | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63736-200-95 | Anacin | 750 in 1 BOX | TABLET | 750 | 9 | |
| 63736-200-95 | Anacin | 1 in 1 POUCH | TABLET | 1 | 9 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Aspirin | ACTIVE INGREDIENT | R16CO5Y76E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Caffeine | ACTIVE INGREDIENT | 3G6A5W338E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Aspirin | ACTIVE MOIETY | R16CO5Y76E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| Caffeine | ACTIVE MOIETY | 3G6A5W338E | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin | ASPIRIN | PD-Rx Pharmaceuticals, Inc. | 98c30922-c48c-471a-a72e-50020a11da98 | 2026-10-08 | Warnings | M013 |
| Mejoralito | ACETAMINOPHEN | OPMX | 5a963a92-e29d-05ba-e063-6394a90a3a47 | 2026-10-08 | Warnings | M013 |
| Pentrexcilina | ACETAMINOPHEN | OPMX LLC | 5a98e123-8e28-6732-e063-6394a90a010c | 2026-10-08 | Warnings | M013 |
| aspirin | ASPIRIN | CVS Pharmacy | bd11081f-c5d1-4c98-8f5a-4c45269df79b | 2026-10-07 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN TABLETS 500 MG | WALGREENS | c25bcfdc-3119-0e8e-e053-2995a90a9e49 | 2026-10-07 | Warnings | M013 |
| Aspirin 81mg | ASPIRIN | Gendose Pharmaceuticals, LLC | 1d6552e8-4f89-411f-a352-8f7835851fc0 | 2026-10-06 | Warnings | M013 |
| Aspirin 81mg Enteric Coated | ASPIRIN | Gendose Pharmaceuticals, LLC | 7342bbf4-ebb9-446d-83bb-6ddcb3a44fa7 | 2026-10-06 | Warnings | M013 |
| BupropiDex | DEXTROMETHORPHAN HYDROBROMIDE | DXM Pharmacuetical, Inc. | 90cc9bcd-7891-4324-a1f4-f6df7a0457e0 | 2026-10-06 | Warnings | M013 |
| Dextabs | DEXTROMETHORPHAN HYDROBROMIDE | DXM Pharmacuetical, Inc. | 71b567df-844a-4563-b85a-f4592233f37d | 2026-10-06 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Major Pharmaceuticals | e1a55e0d-bb86-4515-8436-51a74b403685 | 2026-10-05 | Warnings | M013 |
| AMAZON BASIC CARE ACETAMINOPHEN | ACETAMINOPHEN | Amazon.com Services LLC | 4b91d807-46fe-65a2-e063-6294a90a7932 | 2026-10-05 | Warnings | M013 |
| Vicks PainQuil PAIN RELIEVER | ACETAMINOPHEN | The Procter & Gamble Manufacturing Company | 0ad7b313-5d72-4cc0-97f0-1a30770350af | 2026-10-05 | Warnings | M013 |
| Vicks PainQuil PM PAIN RELIEVER plus NIGHTTIME SLEEP-AID | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | The Procter & Gamble Manufacturing Company | 65803fcd-3f5b-4c9d-85a1-2bf03ed6f68d | 2026-10-05 | Warnings | M013 |
| Vicks PainQuil and Vicks PainQuil PM PAIN RELIEVER | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | The Procter & Gamble Manufacturing Company | 163a1617-b7f1-4c80-e063-6394a90a74c3 | 2026-10-05 | Warnings | M013 |
| Vicks PainQuil PAIN RELIEVER | ACETAMINOPHEN | The Procter & Gamble Manufacturing Company | 32841eaa-87ce-5f23-e063-6294a90a9118 | 2026-10-05 | Warnings | M013 |
| Vicks PainQuil and Vicks PainQuil PM PAIN RELIEVER | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | The Procter & Gamble Manufacturing Company | 334f3194-9737-8f85-e063-6394a90ad416 | 2026-10-05 | Warnings | M013 |
| Vicks PainQuil and Vicks PainQuil PM LIQUICAPS PAIN RELIEVER | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | The Procter & Gamble Manufacturing Company | 4b829c72-349a-e52c-e063-6394a90aca8d | 2026-10-05 | Warnings | M013 |
| Vicks PainQuil PM LIQUICAPS PAIN RELIEVER plus NIGHTTIME SLEEP-AID | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | The Procter & Gamble Manufacturing Company | 4b1ad683-9b5a-622f-e063-6294a90a475c | 2026-10-05 | Warnings | M013 |
| Vicks PainQuil LIQUICAPS PAIN RELIEVER | ACETAMINOPHEN | The Procter & Gamble Manufacturing Company | 4b1b0e2a-0f58-c3b1-e063-6294a90aa1fb | 2026-10-05 | Warnings | M013 |
| Med365 Pain Relief | ACETAMINOPHEN | Shield Pharmaceuticals Corp. | 3142a6b6-752f-402c-8bc1-a762ba879c49 | 2026-10-05 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 211292 | ANACIN 400 MG / 32 MG Oral Tablet | PSN | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | aspirin 400 MG / caffeine 32 MG Oral Tablet | PSN | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin] | SBD | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | aspirin 400 MG / caffeine 32 MG Oral Tablet | SCD | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | Anacin (ASA 400 MG / caffeine 32 MG) Oral Tablet | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 198479 | ASA 400 MG / Caffeine 32 MG Oral Tablet | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
| 211292 | ASA 400 MG / Caffeine 32 MG Oral Tablet [Anacin] | SY | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63736-200-91 | 63736020091 | 1 BOTTLE in 1 BOX (63736-200-91) > 130 TABLET in 1 BOTTLE | 1 bottle | 2009-06-25 | 2023-06-30 | No | No | Current |